U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07397728) titled '" TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus' on Jan. 23.
Brief Summary: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by diverse clinical manifestations, prominently involving the skin.
Study Start Date: June 10, 2025
Study Type: OBSERVATIONAL
Condition:
Systemic Lupus Erythematosus
Intervention:
DIAGNOSTIC_TEST: TREX1 gene polymorphisms
To assess the prevalence of selected autoantibodies as (anti-dsDNA, anti-Sm, anti-Ro/SSA, anti-La/SSB) and TREX1 gene polymorphisms in SLE patients, and their association with clinical features and disease activity
Recruitment ...